Search results for "Adverse effect"

showing 10 items of 1065 documents

Obstetric and perinatal outcome of babies born from vitrified oocytes.

2013

Objective To assess outcomes after oocyte vitrification on obstetric and perinatal outcomes compared with those achieved with fresh oocytes. Design Retrospective cohort study. Setting Private university-affiliated IVF center. Patient(s) Children born after use of vitrified oocytes (1,027 from 804 pregnancies) and fresh oocytes (1,224 from 996 pregnancies). Singleton and multiples pregnancies from own and donated ova were included. Intervention(s) Oocyte vitrification by the Cryotop method. Main Outcome Measure(s) Pregnancy, delivery, and neonatal outcomes. Result(s) Vitrification had no clinically relevant adverse effects on obstetric and perinatal outcomes after adjusting for potential con…

Adultmedicine.medical_specialtyNeonatal intensive care unitBirth weightOocyte RetrievalFertilization in VitroRisk AssessmentPregnancyRisk FactorsmedicineOdds RatioHumansAdverse effectRetrospective StudiesGynecologyCryopreservationPregnancyChi-Square Distributionbusiness.industryObstetricsPregnancy OutcomeObstetrics and GynecologyGestational ageRetrospective cohort studyOdds ratiomedicine.diseaseVitrificationConfidence intervalPregnancy ComplicationsLogistic ModelsTreatment OutcomeReproductive MedicineInfertilityMultivariate AnalysisOocytesFemalebusinessFertility and sterility
researchProduct

Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions

2007

OBJECTIVE: Limited information exists regarding the association between markers of inflammation, such as high-sensitivity C-reactive protein (hs-CRP) and fibrinogen, and adverse events in postmenopausal women with subclinical atherosclerosis. Therefore, we investigated the prognostic impact of traditional risk factors and inflammation on adverse cardiac events in women with asymptomatic carotid lesions. DESIGN: We studied 250 postmenopausal women who were free of cardiovascular disease. Traditional cardiovascular risk factors were investigated, and laboratory analysis included measurement of plasma lipids, fibrinogen, and hs-CRP. The early phases of carotid atherosclerosis were assessed by …

Adultmedicine.medical_specialtyPathologySettore MED/09 - Medicina Internaclinical eventsMyocardial InfarctionmenopauseInflammationFibrinogenAsymptomaticcarotid atherosclerosiRisk FactorsInternal medicineOdds RatiomedicineHumansMyocardial infarctionAdverse effectStrokeAgedbiologybusiness.industryC-reactive proteinAge FactorsFibrinogenObstetrics and GynecologyOdds ratioMiddle AgedAtherosclerosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareStrokeC-Reactive ProteinCarotid Arteriesinflammationbiology.proteinFemaleRisk factormedicine.symptomTunica IntimaTunica MediabusinessBiomarkersFollow-Up Studiesmedicine.drugMenopause
researchProduct

A pilot study of laparoscopic adhesion prophylaxis after myomectomy with a copolymer designed for endoscopic application.

2009

Abstract Study Objective To assess the laparoscopic handling and safety of D,L-polylactide-e-caprolactone-trimethylene carbonate (PCT) copolymer after myomectomy and compare it with icodextrin. In contrast to previously developed solid barriers, the material has rationally designed properties that are advantageous for convenient laparoscopic application. Design A randomized, single-blinded clinical study (Canadian Task Force Classification I). Setting Single-center study in a German University Hospital. Patients Thirty patients who underwent laparoscopic myomectomy were enrolled. Interventions After laparoscopic myomectomy and subsequent reconstruction of the uterus with interrupted sutures…

Adultmedicine.medical_specialtyRandomizationPolyestersAdhesion (medicine)Pilot ProjectsTissue AdhesionsPeritoneal DiseasesIcodextrinIcodextrinmedicineHumansSingle-Blind MethodAdverse effectLaparoscopyGlucansmedicine.diagnostic_testLeiomyomabusiness.industryPelvic painSuture TechniquesObstetrics and GynecologyAdhesion barriermedicine.diseaseSurgerymedicine.anatomical_structureGlucoseTreatment OutcomeUterine NeoplasmsAbdomenFemaleLaparoscopymedicine.symptombusinessFollow-Up StudiesJournal of minimally invasive gynecology
researchProduct

Progestogens to prevent preterm birth in twin pregnancies:an individual participant data meta-analysis of randomized trials

2012

Abstract Background Preterm birth is the principal factor contributing to adverse outcomes in multiple pregnancies. Randomized controlled trials of progestogens to prevent preterm birth in twin pregnancies have shown no clear benefits. However, individual studies have not had sufficient power to evaluate potential benefits in women at particular high risk of early delivery (for example, women with a previous preterm birth or short cervix) or to determine adverse effects for rare outcomes such as intrauterine death. Methods/design We propose an individual participant data meta-analysis of high quality randomized, double-blind, placebo-controlled trials of progestogen treatment in women with …

Adultmedicine.medical_specialtyReproductive medicine/dk/atira/pure/subjectarea/asjc/2700/2729lcsh:Gynecology and obstetricslaw.inventionStudy ProtocolClinical ProtocolsRandomized controlled trialPregnancylawObstetrics and GynaecologymedicineHumansAdverse effectTwin Pregnancylcsh:RG1-991Randomized Controlled Trials as TopicPregnancyModels StatisticalObstetricsbusiness.industryIndividual participant dataInfant NewbornPregnancy OutcomeObstetrics and Gynecologymedicine.diseasePregnancy ComplicationsPremature birthMeta-analysisPregnancy TwinPremature BirthFemaleProgestinsbusiness
researchProduct

Upper-Body Exercises With External Resistance Are Well Tolerated and Enhance Muscle Activity in People With Hemophilia

2019

Abstract Background Conventional nonresisted therapeutic exercises for people with hemophilia involve a careful, low-intensity approach to avoid injuries. Externally resisted exercise is highly efficient for increasing muscle strength in healthy adults but its feasibility for people with hemophilia remains unknown. Objective The purpose of this study was to evaluate muscle activity during upper-body rehabilitation exercises with 2 types of external resistance and without external resistance (conventional) and to examine tolerability, kinesiophobia, and possible adverse effects derived from the session. Design This was a cross-sectional study. Methods Twelve people with hemophilia A/B (11 wi…

Adultmedicine.medical_specialtyShouldermedicine.medical_treatmentElbowDeltoid curvePhysical Therapy Sports Therapy and RehabilitationElectromyographyHemophilia ABicepsUpper Extremity03 medical and health sciences0302 clinical medicinemedicineElbowHumans030212 general & internal medicineMuscle StrengthAdverse effectRehabilitationmedicine.diagnostic_testbusiness.industryElectromyographyResistance Trainingmedicine.anatomical_structureCross-Sectional StudiesTolerabilityExternal resistancePhysical therapybusiness030217 neurology & neurosurgery
researchProduct

Heavy Resistance Training in Breast Cancer Patients Undergoing Adjuvant Therapy.

2019

BACKGROUND AND PURPOSE Adjuvant breast cancer therapy may reduce maximal muscle strength, muscle mass, and functional performance. Although maximal strength training (MST) has the potential to counteract this debilitating outcome and is shown to be superior to low- and moderate-intensity strength training, it is unknown if it can elicit effective adaptations in patients suffering treatment-induced adverse side effects. METHODS Fifty-five newly diagnosed stage I to III breast cancer patients (49 ± 7 yr) scheduled for adjuvant therapy were randomized to MST or a control group. The MST group performed 4 × 4 repetitions of dynamic leg press at approximately 90% of one-repetition maximum (1RM) t…

Adultmedicine.medical_specialtyStrength trainingmedicine.medical_treatmentUrologyPhysical Therapy Sports Therapy and RehabilitationBreast NeoplasmsWalkingMastectomy SegmentalBody Mass IndexQuadriceps Muscle03 medical and health sciences0302 clinical medicineBreast cancerAdjuvant therapyMedicineHumansOrthopedics and Sports MedicineMuscle StrengthAdverse effectLeg pressbusiness.industryResistance Training030229 sport sciencesMiddle AgedPhysical Functional Performancemedicine.diseaseQuadriceps femoris muscleRadiation therapyLower ExtremityThighChemotherapy AdjuvantFemaleRadiotherapy Adjuvantbusinesshuman activitiesBody mass indexMedicine and science in sports and exercise
researchProduct

THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS.

2008

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either …

Adultmedicine.medical_specialtyTime FactorsAdolescentInjections Subcutaneoussuboptimal treatment responseGastroenterologyDrug Administration Schedulelaw.inventionYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesAdverse effectProspective cohort studyinterferon beta (IFNβ)immunomodulatory drugSubclinical infectionDose-Response Relationship Drugbusiness.industryInterferon beta-1bInterferon-betaMiddle AgedMagnetic Resonance ImagingConfidence intervalSurgeryClinical trialTreatment OutcomeNeurologyRelative riskmultiple sclerosiMRI activitySettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesInterferon beta-1b
researchProduct

Cizolirtine Citrate, an Effective Treatment for Symptomatic Patients with Urinary Incontinence Secondary to Overactive Bladder: A Pilot Dose-Finding …

2009

Abstract Background A dose-finding study was performed as the first step in the clinical development of the new drug, cizolirtine citrate. Objective To assess the efficacy and safety of cizolirtine citrate in overactive bladder with urinary incontinence. Design, setting, and participants Seventy-nine outpatients with clinical overactive bladder and/or urodynamic diagnosis of detrusor overactivity were randomized in a multicentre, 12-wk, double-blind, pilot trial. Interventions Patients received cizolirtine citrate 400mg bid (C400), cizolirtine citrate 200mg bid (C200), or placebo. Measurements Patients recorded efficacy variables in 7- and 14-d bladder diaries: urinary incontinence episodes…

Adultmedicine.medical_specialtyVomitingCalcitonin Gene-Related PeptideUrologyUrinary systemVision DisordersUrologyPilot ProjectsUrinary incontinenceSubstance PPlaceboDizzinesslaw.inventionYoung AdultDouble-Blind MethodRandomized controlled triallawmedicineHumansAdverse effectAgedAged 80 and overUrinary bladderDose-Response Relationship DrugUrinary Bladder Overactivebusiness.industryNauseaMiddle Agedmedicine.diseaseUrodynamicsUrinary Incontinencemedicine.anatomical_structureTolerabilityOveractive bladderPyrazolesFemalemedicine.symptombusinessEuropean Urology
researchProduct

Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.

2017

Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety in daily clinical practice. The overall response rate was 54.8% (n = 22, with a complete response in 38.1%) with a median time to response of 29 days (24-41 days). Patients with complete response had shorter disease duration whereas no difference was observed between responders and non-responders regarding age, sex or previous treatments received. Importantly, after dapsone withdrawal, a sustained response was ob…

Adultmedicine.medical_specialtymedicine.medical_treatmentSplenectomylcsh:Medicine030204 cardiovascular system & hematologyDapsone03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansAdverse effectlcsh:ScienceRetrospective StudiesSecond-line therapyPurpura Thrombocytopenic IdiopathicMultidisciplinarybusiness.industrylcsh:RRetrospective cohort studyImmune thrombocytopeniaSurgerySustained responseCohortlcsh:QbusinessDapsone030215 immunologymedicine.drugResearch ArticlePloS one
researchProduct

Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.

2020

Background and purpose The purpose was to report the results of ultrasound-guided lumbar puncture for the administration of nusinersen in spinal muscular atrophy (SMA) patients with complex spines. Methods Eighteen SMA patients (five children, five adolescents and eight adults) with either severe scoliosis or spondylodesis were evaluated for ultrasound-guided lumbar puncture. Ultrasound was performed with a 3.5 MHz transducer to guide a 22 gauge × 15 mm needle, which was placed in the posterior lumbar space following a parasagittal interlaminar approach. Results Twelve patients had undergone spinal instrumentation (nine growing rods and three spinal fusion) whilst the other six showed sever…

Adultmusculoskeletal diseasesmedicine.medical_specialtyAdolescentlumbar puncture nusinersen spinal muscular atrophy ultrasound complex spine and intrathecalmedicine.medical_treatmentOligonucleotidesSpinal PunctureMuscular Atrophy Spinal03 medical and health sciences0302 clinical medicineLumbarmedicineHumans030212 general & internal medicineAdverse effectChildUltrasonography Interventionalmedicine.diagnostic_testbusiness.industryLumbar punctureUltrasoundSpinal muscular atrophySMA*medicine.diseaseSurgeryNeurologySpinal fusionNusinersenNeurology (clinical)business030217 neurology & neurosurgery
researchProduct